Alzheimer's drug that slows disease gets backing from FDA advisers
Voice of America
FILE - A U.S. Food and Drug Administration building is seen behind FDA logos in Silver Spring, Maryland, on Aug. 2, 2018. FILE - A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017.
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease.
A Korea Institute of Machinery and Materials researcher controls a wheelchair with stiffness-variable "morphing" wheels in Daejeon, South Korea, Nov. 5, 2024. The "morphing" wheel can roll over obstacles up to 1.3 times the height of its radius. Inspired by the surface tension of water droplets, it goes from solid to fluid when it encounters impediments.
FILE - Part of the temples of Baalbek, a UNESCO world heritage site in Lebanon's eastern Bekaa Valley, illuminated in blue light, Oct. 24, 2015. FILE - This picture shows closed shops on an empty street in the eastern Lebanese city of Baalbek on Oct. 19, 2024. FILE - People walk near the Roman ruins of Baalbek, Lebanon, Jan. 5, 2024. FILE - A man sits amidst the rubble at a site damaged in the aftermath of an Israeli strike on the town of Al-Ain in the Baalbek region, amid the ongoing hostilities between Hezbollah and Israeli forces, in Lebanon, Nov. 6, 2024.
Dr. Jaafar al Jotheri, shown here Nov. 10, 2024, holds satellite images and explores the site of the Battle of al-Qadisiyah, which was fought in Mesopotamia -- present-day Iraq -- in the 630s AD. A desert area with scattered plots of agricultural land with features that closely matched the description of the al-Qadisiyah battle site described in historic texts, Nov. 10, 2024.